Last updated on March 28, 2023
Ajanta Pharma Buyback 2023 description – Ajanta Pharma is a specialty pharmaceutical formulation company engaged in the development, manufacturing, and marketing of finished dosages. The company has a well-diversified business model in terms of markets, therapies, and products.
The company has de-risked the business to a large extent from possible uncertainties in the business environment in different geographies. The largest contribution of about 73% of business comes from a wide range of branded generic products in around 30 countries in Asia (including India) and Africa.
Each geography has been carefully chosen for therapies and products. Additionally, about 21% comes from the generics business in the world’s largest market the USA, and the remaining 6% comes from anti-malaria institutional business in Africa.
Ajanta Pharma operates 7 state-of-the-art manufacturing facilities in India. Out of this, 6 facilities manufacture finished formulations and 1 manufactures Active Pharmaceutical Ingredients (APIs), primarily for captive consumption.
Ajanta Pharma share Buyback 2023 Details
| Ajanta Pharma Buyback Dates | 31 March – 10 April 2023 |
| Ajanta Pharma Buyback Price | INR 1,425 per share |
| Market Price on Buyback Approval | INR 1,215.65 per share |
| Buyback Premium on Market Price | 17.22% |
| Buyback Offer Size (Shares) | 22,10,500 shares |
| Buyback Offer Size (Amount) | INR 315 crore |
| Offer Type | Tender Offer |
| Promoter Participation | Yes |
| Face Value | INR 2 per share |
| Listing At | BSE, NSE |
Ajanta Pharma Buyback Dates (Timeline)
| Board Meeting Intimation for Buyback Proposal | 6 March 2023 |
| Buyback Approval Date | 10 March 2023 |
| Public Announcement of Buyback | 14 March 2023 |
| Ajanta Pharma Buyback Record Date | 24 March 2023 |
| Buyback Opening Date | 31 March 2023 |
| Buyback Closing Date | 10 April 2023 |
| Cut-off Date to receive completed tender forms by Registrar | 10 April 2023 |
| Verification Date by the Registrar | 13 April 2023 |
| Return of unaccepted shares by Registrar | 18 April 2023 |
| Extinguishment of accepted shares | 27 April 2023 |
Ajanta Pharma Buyback 2023 Documents
Letter of Offer
Draft Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback
Ajanta Pharma Buyback Entitlement Ratio
| Shareholder Category | Entitlement Ratio | Entitlement Ratio (in %) |
| Small Shareholders (less than INR 2 Lakh on record date) | 20/99 | 20.20 |
| General category (for all other Eligible Shareholders) | 3/202 | 1.49 |
Small Shareholder is defined as shareholder who holds shares worth less than INR 2,00,000 as on record date.
Ajanta Pharma Financial Performance
| FY 2020 | FY 2021 | FY 2022 | |
| Revenue | 2,587.87 | 2,889.69 | 3,340.99 |
| Total Expenses | 2,012.17 | 2,015.49 | 2,547.19 |
| Net income | 467.7 | 653.87 | 712.68 |
Calculation of Investment in Buyback
| Maximum market value of a share holder as on record date | INR 2,00,000 |
| Buyback price per share | INR 1,425 |
| Maximum shares for small shareholder (2,00,000/1,425) | 141 shares * |
| Closing price of stock as on 10 March 2023 | INR 1,215.65** |
| Maximum amount invested in buyback (INR 1,215.65 x 141 shares) | INR 171,407 |
** For simplicity, we have considered price on buyback approval date
Ajanta Pharma Buyback Profit Guidance
| Shares Tendered | Buyback Entitlement | Acceptance ratio | Buyback Profit | Profit in % |
| 141 | 29 | 29 (100%) | 6,071.15 | 3.54 |
| 141 | 29 | 58 (200%) | 12,142.3 | 7.08 |
| 141 | 29 | 87 (300%) | 18,213.45 | 10.63 |
Registrar of Ajanta Pharma Buyback 2023
LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park
L.B.S. Marg, Vikhroli West
Mumbai – 400 083, Maharashtra
Phone:Â +918108114949
Email:Â [email protected]
Website: www.linkintime.co.in
Manager of Ajanta Pharma Buyback 2023
EDELWEISS FINANCIAL SERVICES LIMITED
6th Floor, Edelweiss House, Off C.S.T. Road,
Kalina, Mumbai 400 098, Maharashtra, India
Tel: +91 22 4009 4400
Email: [email protected]
Website: www.edelweissfin.com
Process to Participate in Ajanta Pharma Buyback
All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stock broker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.
The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.
The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.
Frequently Asked Questions
What are Ajanta Pharma’s share buyback dates?
Ajanta Pharma’s share buyback opens on 31 March 2023 and closes on 10 April 2023.
Which type of buyback is Ajanta Pharma buyback offer?
Ajanta Pharma’s buyback is a tender offer.
What is Ajanta Pharma buyback price?
Ajanta Pharma buyback price is INR 1,425 per share.
What is Ajanta Pharma buyback record date?
Ajanta Pharma buyback record date is 24 March 2023.
How to participate in Ajanta Pharma share buyback?
Ajanta Pharma share buyback will be conducted through tender process and investors who hold the shares on record date can place orders through their broker.
